The Effects of Association of Topical Polydatin Improves the Preemptive Systemic Treatment on EGFR Inhibitors Cutaneous Adverse Reactions

Epidermal Growth Factor Receptor inhibitors (EGFRi) are approved as therapeutic options in several solid tumors. Cutaneous papulopustular eruption is the most frequent cutaneous adverse-event (AE), usually treated with emollient or corticosteroids according to toxicity grade. Our study evaluated the...

Descripción completa

Detalles Bibliográficos
Autores principales: Bavetta, Mauro, Silvaggio, Dionisio, Campione, Elena, Sollena, Pietro, Formica, Vincenzo, Coletta, Deborah, Graziani, Grazia, Romano, Maria Concetta Pucci, Roselli, Mario, Peris, Ketty, Bianchi, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7866016/
https://www.ncbi.nlm.nih.gov/pubmed/33530427
http://dx.doi.org/10.3390/jcm10030466

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7866016/
https://www.ncbi.nlm.nih.gov/pubmed/33530427
http://dx.doi.org/10.3390/jcm10030466

Ejemplares similares